|
Market Closed -
Nasdaq
16:00:00 2026-01-16 EST
|
5-day change
|
1st Jan Change
|
|
68.67 USD
|
-1.84%
|
 |
+4.52%
|
+16.77%
|
|
01-09 |
Stephens Adjusts Bio-Techne Price Target to $80 From $70, Maintains Overweight Rating
|
MT
| |
01-06 |
Evercore ISI Downgrades Bio-Techne to In Line From Outperform, Adjusts PT to $62 From $68
|
MT
| |
12-12 |
Deutsche Bank Adjusts Price Target on Bio-Techne to $72 From $66, Maintains Buy Rating
|
MT
| |
12-12 |
Deutsche Bank Raises Price Target on Bio-Techne to $72 From $66, Keeps Buy Rating
|
MT
| |
11-20 |
Argus Adjusts Price Target on Bio-Techne to $68 From $65, Maintains Buy Rating
|
MT
| |
11-06 |
Wells Fargo Adjusts Bio-Techne Price Target to $70 From $59, Maintains Overweight Rating
|
MT
| |
11-06 |
Baird Adjusts Bio-Techne Price Target to $61 From $62, Maintains Neutral Rating
|
MT
| |
11-06 |
Stephens Adjusts Bio-Techne Price Target to $70 From $65, Maintains Overweight Rating
|
MT
| |
11-06 |
UBS Adjusts Price Target on Bio-Techne to $70 From $65, Maintains Buy Rating
|
MT
| |
11-05 |
Evercore ISI Adjusts Price Target on Bio-Techne to $68 From $72
|
MT
| |
25-10-30 |
Baird Adjusts Price Target on Bio-Techne to $62 From $53
|
MT
| |
25-10-14 |
TD Cowen Adjusts Price Target on Bio-Techne to $70 From $65, Maintains Buy Rating
|
MT
| |
25-10-07 |
Evercore ISI Adjusts Price Target on Bio-Techne to $72 From $60, Maintains Outperform Rating
|
MT
| |
25-09-03 |
Bio-Techne Seen With Potential Upside From M&A Deals, RBC Says
|
MT
| |
25-09-03 |
Analyst recommendations: Accenture, Chipotle, Kraft, Lucid Group, Thor Industries…
|  | |
25-09-03 |
RBC Capital Upgrades Bio-Techne to Outperform From Sector Perform, Adjusts PT to $73 From $61
|
MT
| |
25-08-21 |
The Bubble Flickers
| | |
25-08-21 |
Citigroup Upgrades Bio-Techne to Buy From Neutral, Adjusts Price Target to $70 From $55
|
MT
| |
25-08-21 |
Analyst recommendations: Coreweave, Coty, Marvell, Snap, AMD…
| | |
25-08-07 |
Baird Adjusts Bio-Techne Price Target to $53 From $58, Maintains Neutral Rating
|
MT
| |
25-08-07 |
Leerink Partners Adjusts Bio-Techne Price Target to $75 From $80, Maintains Outperform Rating
|
MT
| |
25-08-07 |
RBC Lowers Price Target on Bio-Techne to $61 From $63, Keeps Sector Perform Rating
|
MT
| |
25-07-31 |
Baird Adjusts Price Target on Bio-Techne to $58 From $51
|
MT
| |
25-07-09 |
TD Cowen Initiates Bio-Techne at Buy With $65 Price Target
|
MT
| |
25-06-05 |
Deutsche Bank Adjusts Bio-Techne Price Target to $66 From $70
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
